Nuvo Pharmaceuticals Inc (NRI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Nuvo Pharmaceuticals Inc (NRI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH63105D
  • |
  • Pages: 49
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Nuvo Pharmaceuticals Inc (Nuvo), formerly known as Nuvo Research Inc is a drug company that offers topical pain products and technologies. The company's product portfolio includes pennsaid, pennsaid 2%, and heated lidocaine and tetracaine patches. Its products deliver drugs topically into and through the skin to the specific site of activity. Nuvo's pennsaid and pennsaid 2%, transdermal drug carriers, used for the treatment of osteoarthritis of the knee. heated lidocaine/tetracaine patch, a topical patch, acts as a local analgesia. The company markets its products through a network of distributors in Canada, European Union Zone and the US. Its manufacturing facility is located in Varennes, Motreal, Quebec, Canada. Nuvo Pharmaceuticals is headquartered in Mississauga, Ontario, Canada.

Nuvo Pharmaceuticals Inc (NRI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Nuvo Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 10

Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 13

Asset Purchase 13

Nuvo Research Reacquires Pennsaid Rights from Paladin Labs 13

Partnerships 14

Nuvo Research Enters Into Co-Development Agreement With Ferndale Labs And Contract Research Organization 14

Nuvo Research Enters Into Distribution Agreement With NovaMedica For Pennsaid 15

Licensing Agreements 16

Sayre Therapeutics Enters into Licensing Agreement with Nuvo Pharma 16

Nuvo Research Enters into Licensing Agreement with Galderma Pharma for Pliaglis 16

Nuvo Research Enters Into Licensing Agreement With Paladin Labs For Synera 17

Equity Offering 18

Nuvo Research Completes Private Placement Of Units For US$2.8 Million 18

Asset Transactions 19

Horizon Pharma Acquires US Rights to Pennsaid 2% from Nuvo Research for USD45 Million 19

Galen Acquires US Rights For Synera From Nuvo Research For USD14.5 Million 21

Tioga Acquires HTE Formulation Patents from Nuvo Research 22

Acquisition 23

Nuvo Research Acquires 40% Stake in Nuvo Research AG 23

Nuvo Research Acquires ZARS Pharma 24

Nuvo Pharmaceuticals Inc-Key Competitors 26

Key Employees 27

Locations And Subsidiaries 28

Head Office 28

Other Locations & Subsidiaries 28

Recent Developments 29

Financial Announcements 29

May 10, 2017: Nuvo Pharmaceuticals Announces 2017 First Quarter Results 29

Mar 01, 2017: Nuvo Pharmaceuticals Announces 2016 Year-End and Fourth Quarter Results 31

Nov 10, 2016: Nuvo Pharmaceuticals Announces 2016 Third Quarter Results 34

Aug 10, 2016: Nuvo Pharmaceuticals Announces 2016 Second Quarter Results 37

May 11, 2016: Nuvo Pharmaceutical Announces 2016 First Quarter Results 39

Feb 17, 2016: Nuvo Research Announces 2015 Fourth Quarter & Year-End Results 41

Jan 21, 2016: Nuvo Research Provides Estimated Revenue for the 2015 Fourth Quarter and Year End 43

Corporate Communications 44

Nov 16, 2016: Nuvo Pharmaceuticals appoints new president 44

Nov 16, 2016: Nuvo Pharmaceuticals Appoints Jesse Ledger as President 45

Sep 01, 2016: Nuvo Pharmaceuticals Appoints New Chief Financial Officer 46

Legal and Regulatory 47

Feb 24, 2016: Nuvo Research Obtains Final Court Order Approving Reorganization into Two Publicly-Traded Companies 47

Other Significant Developments 48

Mar 01, 2016: Nuvo Research Completes Reorganization into Two Publicly Traded Companies 48

Appendix 49

Methodology 49

About GlobalData 49

Contact Us 49

Disclaimer 49

List of Figures

Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Nuvo Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 10

List of Tables

Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1

Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Nuvo Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 9

Nuvo Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 10

Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

Nuvo Research Reacquires Pennsaid Rights from Paladin Labs 13

Nuvo Research Enters Into Co-Development Agreement With Ferndale Labs And Contract Research Organization 14

Nuvo Research Enters Into Distribution Agreement With NovaMedica For Pennsaid 15

Sayre Therapeutics Enters into Licensing Agreement with Nuvo Pharma 16

Nuvo Research Enters into Licensing Agreement with Galderma Pharma for Pliaglis 16

Nuvo Research Enters Into Licensing Agreement With Paladin Labs For Synera 17

Nuvo Research Completes Private Placement Of Units For US$2.8 Million 18

Horizon Pharma Acquires US Rights to Pennsaid 2% from Nuvo Research for USD45 Million 19

Galen Acquires US Rights For Synera From Nuvo Research For USD14.5 Million 21

Tioga Acquires HTE Formulation Patents from Nuvo Research 22

Nuvo Research Acquires 40% Stake in Nuvo Research AG 23

Nuvo Research Acquires ZARS Pharma 24

Nuvo Pharmaceuticals Inc, Key Competitors 26

Nuvo Pharmaceuticals Inc, Key Employees 27

Nuvo Pharmaceuticals Inc, Subsidiaries 28

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Nuvo Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16120
Site License
USD 500 INR 32240
Corporate User License
USD 750 INR 48360

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com